Agilent Technologies, Inc. (A)

In the past six months, Agilent Technologies' stock has experienced a decline. As of March 18, 2025, the stock had fallen 10.2% over the preceding three months and 16.9% over the past 52 weeks. Year-to-date, shares were down 8.8%. The stock has been trading below its 200-day and 50-day moving averages since mid-February 2025. Key events impacting the stock price include earnings reports, analyst ratings downgrades, market underperformance due to struggles in key end markets, a dividend announcement of 24.8 cents per share on May 21, 2025, and product and leadership announcements.

Demand for Agilent Technologies' products and services exhibits seasonality, primarily influenced by budgeting cycles. The company's life sciences and diagnostics business, as well as its chemical analysis business, are susceptible to seasonality in orders and revenues, largely driven by U.S. and foreign government budgets and the budgets of large pharmaceutical companies. The markets in which Agilent operates are generally considered seasonal and cyclical. Historically, the demand for chip and chip-equipment, which Agilent's products can be linked to, has shown seasonal strength in the fourth quarter.

Agilent Technologies, Inc. is a global multinational company specializing in scientific instruments, laboratory equipment, software, consumables, and services for analytical laboratories. It operates within the Healthcare Equipment & Supplies sector, focusing on Biotechnology: Laboratory Analytical Instruments. Agilent offers solutions across life sciences, diagnostics, and applied chemical markets, serving diverse industries. Agilent's major products include analytical instruments, consumables, and services, such as liquid chromatography systems, mass spectrometry systems, and gas chromatography systems. The company also provides reagents, laboratory software, information management and analytics solutions, laboratory automation and robotic systems, and measurement technologies. In diagnostics and genomics, Agilent offers products for genomics, immunohistochemistry, and cell analysis. Agilent provides comprehensive services through its Agilent CrossLab segment, including repairs, maintenance, training, and consulting services.

Agilent Technologies maintains a strong global presence, operating in over 110 countries worldwide. The company's headquarters are located in Santa Clara, California, U.S. Agilent serves customers across Europe, the Americas, and Asia Pacific. Its research labs also have offices in Europe, Asia, and the United States. The company has been recognized as a Great Place to Work in 27 countries and territories.

Agilent Technologies has a strong brand reputation built on innovation, quality, and customer satisfaction. In the past year, Agilent was ranked No. 11 on Fortune's list of Best Workplaces in the World and was named a top employer by Forbes and Newsweek. Agilent released its annual ESG report in June 2024, highlighting its sustainable solutions for laboratories, including instrument recycling and refurbishment programs. The company has reduced its Scope 1 and 2 emissions by 8% since 2019 and has received validation for its net-zero emissions targets.

Agilent Technologies, Inc. is a publicly traded company with ownership distributed among various shareholders. Institutional investors hold approximately 87.43% of the company's outstanding shares. The largest institutional shareholders include Vanguard Group, BlackRock, and State Street Corporation. Insider ownership stands at approximately 0.30%. A significant number of retail shareholders also own shares in the company.